Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
Clinical trial NCT02207361 · UNKNOWN
Trial details
- NCT number
- NCT02207361
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.